LHDX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mar 2023 @ 22:00):

Stats
Dagens volum	36.26M
Gjennomsnittsvolum	21.45M
Markedsverdi	18.36M
EPS	$0 ( 2023-05-10 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.144
ATR14	$0.0630 (13.93%)

Insider Trading

Date	Person	Action	Amount	type
2023-03-03	Engelson Erik T.	Buy	574 666	Common Stock
2023-03-03	Engelson Erik T.	Sell	574 666	Common Stock
2023-03-03	Engelson Erik T.	Sell	60 000	Common Stock
2023-03-03	Engelson Erik T.	Sell	574 666	Common Stock
2023-03-03	Narido Richard Clavano	Sell	10 674	Common Stock

INSIDER POWER
-77.80
Last 96 transactions
Buy: 17 602 742 \| Sell: 22 464 128

Volum Korrelasjon

Lang: 0.09 (neutral)

Kort: 0.47 (neutral)

Signal:(52.543) Neutral

Lucira Health, Inc. Korrelasjon

10 Mest positive korrelasjoner
XPDI	0.906
GOODM	0.898
FATE	0.897
PIII	0.889
SMIT	0.884
MGPI	0.882
PROC	0.872
HECCU	0.871
ODT	0.871
EYEG	0.867

10 Mest negative korrelasjoner
IPVI	-0.899
IQ	-0.889
FRGI	-0.887
CCRC	-0.876
TIG	-0.869
CTIB	-0.868
XFIN	-0.866
STAY	-0.865
DSPG	-0.863
BTWN	-0.86

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Lucira Health, Inc. Korrelasjon - Valuta/Råvare

0.86
( strong )

0.81
( strong )

0.00
( neutral )

0.73
( moderate )

-0.39
( neutral )

-0.71
( moderate negative )

Lucira Health, Inc. Økonomi

Annual	2021
Omsetning:	$93.06M
Bruttogevinst:	$10.22M (10.99 %)
EPS:	$-1.807

FY	2021
Omsetning:	$93.06M
Bruttogevinst:	$10.22M (10.99 %)
EPS:	$-1.807

FY	2020
Omsetning:	$269 000
Bruttogevinst:	$-1.67M (-621.56 %)
EPS:	$-1.041

FY	2019
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.070

Financial Reports:

No articles found.

Lucira Health, Inc.

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.